GL1X · GenesisL1 explorer

Research workbench

Structural studies of HIV and fiv proteases complexed with an efficient inhibitor of fiv pr

Analyse Structural studies of HIV and fiv proteases complexed with an efficient… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5FIV
Type
protein
Length
112 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retropepsin
EC
3.4.23.16
UniProt
P16088
Ligands
3TL
Pockets
2 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetropepsin (EC 3.4.23.16)protein1129% helix, 45% strandP16088

Ligands and binding sites

  • 3TL · benzyl [(1S,4S,7S,8R,9R,10S,13S,16S)-7,10-dibenzyl-8,9-dihydroxy-1,16-dimethyl-4,13-bis(1-methylethyl)-2,5,12,15,18-pentaoxo-20-phenyl-19-oxa-3,6,11,14,17-pentaazaicos-1-yl]carbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.520.7723empty
21040.360.7420empty

Compared structures

  • 5FIV · Structural studies of HIV and fiv proteases complexed with an efficient inhibitor of fiv… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.